These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 32756466)

  • 1. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
    Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P
    Cells; 2020 Aug; 9(8):. PubMed ID: 32756466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant Transformation of Normal Oral Tissue to Dysplasia and Early Oral Squamous Cell Carcinoma: An
    Jamshidi S; Tavangar M; Shojaei S; Taherkhani A
    Anal Cell Pathol (Amst); 2024; 2024():6260651. PubMed ID: 39376501
    [No Abstract]   [Full Text] [Related]  

  • 3. Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma.
    Bau DT; Lippman SM; Xu E; Gong Y; Lee JJ; Wu X; Gu J
    Cancer; 2013 Dec; 119(24):4277-83. PubMed ID: 24105340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
    Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
    J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
    Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
    Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
    Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Immune-Related Risk Signatures for the Prognostic Prediction in Oral Squamous Cell Carcinoma.
    Zou C; Huang D; Wei H; Wu S; Song J; Tang Z; Li X; Ai Y
    J Immunol Res; 2021; 2021():6203759. PubMed ID: 34497859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
    Lu X; Liu X
    J Healthc Eng; 2022; 2022():6602648. PubMed ID: 35432823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel necroptosis-related LncRNA signature for prognostic prediction and immune response in oral squamous cell carcinoma.
    Ji L; Liang S; Cheng Y; Gao R; Yan W; Pang F; Zhang F
    Cancer Biomark; 2024; 40(3-4):319-342. PubMed ID: 39213052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic landscape of oral squamous cell carcinoma.
    Vitório JG; Duarte-Andrade FF; Dos Santos Fontes Pereira T; Fonseca FP; Amorim LSD; Martins-Chaves RR; Gomes CC; Canuto GAB; Gomez RS
    Metabolomics; 2020 Sep; 16(10):105. PubMed ID: 33000429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathway analysis of a genome‑wide association study on a long non‑coding RNA expression profile in oral squamous cell carcinoma.
    Qiu YL; Liu YH; Ban JD; Wang WJ; Han M; Kong P; Li BH
    Oncol Rep; 2019 Feb; 41(2):895-907. PubMed ID: 30431131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain of hTERC: a genetic marker of malignancy in oral potentially malignant lesions.
    Dorji T; Monti V; Fellegara G; Gabba S; Grazioli V; Repetti E; Marcialis C; Peluso S; Di Ruzza D; Neri F; Foschini MP
    Hum Pathol; 2015 Sep; 46(9):1275-81. PubMed ID: 26170010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revelation of comprehensive cell profiling of primary and metastatic tumour ecosystems in oral squamous cell carcinoma by single-cell transcriptomic analysis.
    Liao YH; Chen L; Feng BH; Lv W; Huang XP; Li H; Li CP
    Int J Med Sci; 2024; 21(12):2293-2304. PubMed ID: 39310253
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.